Figure 1
TDS development pipeline and drug screening flow chart. The proposed compound-screening pipeline includes three phases: the identification of Transcriptional Disease Signature (TDS) genes, the development of data analyses tools, and the testing of the established screening pipeline using compounds that are commonly used for melanoma therapy.
